BioSpace News Archive

AbbVie (NYSE: ABBV) will participate in Bernstein’s 37th Annual Strategic Decisions Conference on Wednesday, June 2, 2021.

Akili Interactive (“Akili” or “Company”), maker of EndeavorRx™, the first and only prescription video game treatment, today announced $160M in combined equity and debt financing.

BryoLogyx Inc., announced today that the Company has named two cancer research leaders, Richard L. Schilsky, MD, FACP, FSCT, FASCO; and Justin Stebbing, MD, PhD to its Scientific and Medical Advisory Board. Dr. Schilsky is former President, Chief Medical Officer and Executive Vice President of ASCO and former Chief of Hematology/Oncology in the Department of Medicine and Deputy Director of the University of Chicago

Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced that the FDA plans to initiate its pre-approval inspection of the company’s manufacturing facility for DaxibotulinumtoxinA for Injection by the end of June 2021.

Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI) a global biotechnology company focused on further improving, applying and deploying its proprietary C1-cell protein production platform to accelerate development, lower production costs and improve the performance of biologic vaccines and drugs at flexible commercial scales, today announced that the Company has entered into a collaboration with Syngene International Limited

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced an upcoming podium presentation on DSUVIA

Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced today that its ovarian cancer vaccine technology is part of an award from the National Cancer Institute (NCI).

Castlight Health, Inc., a leader in healthcare navigation, announced that senior management will participate in the William Blair 41st Annual Growth Stock Conference, including one-on-one meetings and a presentation on Thursday, June 3, 2021 at 3:00 pm ET.

Vikas Sharma, Ph.D., Shirley Lasch, and Tim O’Brien join team dedicated to developing new treatments for ALS and other genetically validated neurodegenerative diseases